SYK as a New Therapeutic Target in B-Cell Precursor Acute Lymphoblastic Leukemia

類似資料

• Absence of Genomic Ikaros/IKZF1 Deletions in Pediatric B-Precursor Acute Lymphoblastic Leukemia
  著者:: Qazi, Sanjive, 等
  出版事項: (2013)
• Incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia
  著者:: Qazi, Sanjive, 等
  出版事項: (2013)
• Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia
  著者:: Uckun, Fatih M., 等
  出版事項: (2015)
• Nanoscale liposomal formulation of a SYK P-site inhibitor against B-precursor leukemia
  著者:: Uckun, Fatih M., 等
  出版事項: (2013)
• STAT3 is a substrate of SYK tyrosine kinase in B-lineage leukemia/lymphoma cells exposed to oxidative stress
  著者:: Uckun, Fatih M., 等
  出版事項: (2010)